Iron deficiency anaemia in pregnancy and its correction
https://doi.org/10.21518/2079-701X-2018-13-73-76
Abstract
The frequency of anaemia in pregnant women varies from 15 to 30%, iron deficiency anaemia (IDA) is the most common disorder, it accounts for about 90% of all anaemia. Iron deficiency adversely affects the course of pregnancy, childbirth, the postpartum period, the condition of the fetus and the newborn. The main complications of pregnancy in IDA are threatened miscarriage (20–42%); preeclampsia (40%); premature separation of placenta (25–35%); intrauterine growth restriction (25%); premature birth (11–42%).
Daily intake of iron-containing drugs is more effective in preventing anaemia in mothers, and in reducing the risk of giving birth to children with low body weight. Daily iron supplementation in preventive programs may reduce the risk of anaemia in the mother at the time of delivery by 70%. It is preferable to take supplements that contain bivalent iron and possess a high degree of absorption, good tolerance by patients and minimal risk of side effects. Complex supplements containing vitamins and microelements are recommended for the treatment and prevention of IDA in pregnant women. Sorbifer Durules is one of such supplements. The Sorbifer Durules therapy of IDA in pregnant is highly effective treatment of therapy, which leads to normalization of hemogram parameters, improvement of the general condition of patients, reduction of obstetric and neonatal complications.
About the Authors
O. V. VavinaRussian Federation
Moscow
T. K. Puchko
Russian Federation
Moscow
M. A. Umralieva
Russian Federation
Moscow
References
1. Burlev VA, Konovodova EN, Murashko LE, Sopoeva ZhA. Correction of iron deficiency in pregnant women with gestosis. Problemy Reproduktsii, 2002, 6: 30-34.
2. Zakharova IN, Zaplatnikov AL, Malova NE. The choice of drugs for ferrotherapy of iron deficiency anaemia in children. RMJ, 2003, 11: 9-15.
3. Pena-Rosas JP, De-Regil LM, Garcia-Casal MN, Dowswell T. Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev, 2015, 7.
4. Froessler B, Collingwood J, Hodyl NA, Dekker G. Intravenous ferric carboxymaltose for anaemia in pregnancy. BMC Pregnancy Childbirth, 2014, 14: 115.
5. Bencaiova G, Burkhardt T, Breymann C. Anemia – prevalence and risk factors in pregnancy. Eur J Intern Med, 2012, 23(6): 529–533. 6. Choudhury N, Aimone A, Hyder SM, Zlotkin SH. Relative efficacy of micronutrient powders versus iron-folic acid tablets in controlling anemia in women in the second trimester of pregnancy. Food Nutr Bull, 2012, 33(2): 142–149.
6. Cotter AM, Molloy AM, Scott JM et al. Elevated plasma homocysteine in early pregnancy: a risk factor for the development of nonsevere preeclampcia. Am J Obstet Gynecol, 2003, 189(2): 391–394.
7. Cogswell ME, Kettel-Khan L, Ramakrishnan U. Iron supplement use among women in the United States: science, policy and practice. J Nutr, 2003, 6: 1974–1977.
8. Shikh EV, Ilenko LI. Clinico-pharmacological aspects of the use of vitamin-mineral complexes in women during pregnancy. M.: Medpraktika-M, 2007. 80 p.
9. Pena-Rosas JP, De-Regil LM, Garcia-Casal MN, Dowswell T. Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev, 2015, 7: CD004736.
10. Choudhury N, Aimone A, Hyder SM, Zlotkin SH. Relative efficacy of micronutrient powders versus iron-folic acid tablets in controlling anemia in women in the second trimester of pregnancy. Food Nutr Bull, 2012, 33(2).
11. Taipurova AM. Complex analysis of the efficacy and tolerability of modern iron supplements for the treatment of anemia in pregnant women. Zhurn. Akusherstva I Zhen. Boleznei, 2005, 54 (4): 26-30.
12. Drukker L, Hants Y, Farkash R et al. Iron deficiency anemia at admission for labor and delivery is associated with an increased risk for Cesarean section and adverse maternal and neonatal outcomes. Transfusion, 2015. doi: 10.1111/trf.13252.
13. Khalafallah AA, Dennis AE, Ogden K et al. Three-year follow-up of a randomised clinical trial of intravenous versus oral iron for anaemia in pregnancy. BMJ Open, 2012, 18: 2-5.
14. Savchenko TN, Agaeva MI, Dergacheva IA. Iron deficiency anaemia as a risk factor for the threatened miscarriage. RMJ, 2014, 1: 46-50.
Review
For citations:
Vavina OV, Puchko TK, Umralieva MA. Iron deficiency anaemia in pregnancy and its correction. Meditsinskiy sovet = Medical Council. 2018;(13):73-76. (In Russ.) https://doi.org/10.21518/2079-701X-2018-13-73-76